Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
16%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
IBRN
74
HOLDINGS
25%
ALSO IN SBIO
SBIO
78
HOLDINGS
17%
ALSO IN IBRN
SECTOR DRIFT (IBRN minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBRN |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 4.3% | 3.3% | 3.3% |
 |
DIANTHUS THERAPEUTICS INC | 3.6% | 2.4% | 2.4% |
|
ACADIA PHARMACEUTICALS INC | 3.6% | 2.2% | 2.2% |
|
EDGEWISE THERAPEUTICS, INC. | 2.8% | 2.1% | 2.1% |
|
DENALI THERAPEUTICS INC. | 3.0% | 1.8% | 1.8% |
IBRN Overweight Relative to SBIO
 |
ARGENX SE ADR | 4.1% |
|
AXSOME THERAPEUTICS, INC. | 4.1% |
|
SCHOLAR ROCK HOLDING CORP. | 4.1% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 4.0% |
|
PTC THERAPEUTICS INC | 4.0% |
|
NEUROCRINE BIOSCIENCES INC | 3.7% |
|
BIOGEN IDEC INC | 3.5% |
|
SUPERNUS PHARMACEUTICALS INC | 3.0% |
|
CATALYST PHARMACEUTICAL PART | 3.0% |
|
DYNE THERAPEUTICS INC | 2.6% |
IBRN Underweight Relative to SBIO
|
KYMERA THERAPEUTICS, INC. | -4.2% |
|
MIRUM PHARMACEUTICALS, INC. | -3.4% |
|
CG ONCOLOGY, INC. | -3.4% |
|
CELCUITY INC. | -3.2% |
|
APELLIS PHARMACEUTICALS, INC. | -3.1% |
|
APOGEE THERAPEUTICS, INC. | -2.9% |
|
AMICUS THERAPEUTICS INC | -2.7% |
|
CRINETICS PHARMACEUTICALS INC | -2.5% |
|
SPYRE THERAPEUTICS INC | -2.4% |
|
NEWAMSTERDAM PHARMA CO NV | -2.4% |